Sex differences in the genetic architecture of susceptibility to Cryptococcus neoformans pulmonary infection

Genes and Immunity

Volumn 9, Issue 6, 2008, Pages 536-545

  Carroll, S F ^a   Loredo Osti, J C ^b   Guillot, L ^a   Morgan, K ^a,c   Qureshi, S T ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^c MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMOSOME 17; CHROMOSOME 3; COLONY FORMING UNIT; CONTROLLED STUDY; CRYPTOCCOCAL PNEUMONIA; CRYPTOCOCCUS NEOFORMANS; FEMALE; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENETIC VARIABILITY; GENOME ANALYSIS; INFECTION CONTROL; INFECTION SENSITIVITY; INFECTIOUS PNEUMONIA; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROGENY; QUANTITATIVE TRAIT LOCUS; SEX DIFFERENCE; TRACHEITIS;

ANIMALS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; IMMUNITY, NATURAL; LUNG; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; PNEUMONIA; QUANTITATIVE TRAIT, HERITABLE; SEX CHARACTERISTICS;

FILOBASIDIELLA NEOFORMANS; MUS;

EID: 51249111290     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2008.48     Document Type: Article

References (62)

1. Chayakulkeeree M, Perfect JR. Cryptococcosis. Infect Dis Clin North Am 2006; 20: 507-544, v-vi.
2. Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS - 100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995; 8: 515-548.
3. Houpt DC, Pfrommer GS, Young BJ, Larson TA, Kozel TR. Occurrences, immunoglobulin classes, and biological activities of antibodies in normal human serum that are reactive with Cryptococcus neoformans glucuronoxylomannan. Infect Immun 1994; 62: 2857-2864.
4. Deshaw M, Pirofski LA. Antibodies to the Cryptococcus neoformans capsular glucuronoxylomannan are ubiquitous in serum from HIV+ and HIV- individuals. Clin Exp Immunol 1995; 99: 425-432.
5. Garcia-Hermoso D, Janbon G, Dromer F. Epidemiological evidence for dormant Cryptococcus neoformans infection. J Clin Microbiol 1999; 37: 3204-3209.
6. Goldman DL, Khine H, Abadi J, Lindenberg DJ, Pirofski L, Niang R et al. Serologic evidence for Cryptococcus neoformans infection in early childhood. Pediatrics 2001; 107: E66.
7. Howard DH. The commensalism of Cryptococcus neoformans. Sabouraudia 1973; 11: 171-174.
8. Mirza SA, Phelan M, Rimland D, Graviss E, Hamill R, Brandt ME et al The changing epidemiology of cryptococcosis: An update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis 2003; 36: 789-794.
9. Vidal SM, Malo D, Marquis JF, Gros P. Forward genetic dissection of immunity to infection in the mouse. Annu Rev Immunol 2008; 26 81-132.
10. Lam-Yuk-Tseung S, Gros P. Genetic control of susceptibility to bacterial infections in mouse models. Cell Microbiol 2003; 5: 299-313.
11. Lengeling A, Pfeffer K, Balling R. The battle of two genomes: Genetics of bacterial host/pathogen interactions in mice. Mamm Genome 2001; 12: 261-271.
12. Rhodes JC, Wicker LS, Urba WJ. Genetic control of susceptibility to Cryptococcus neoformans in mice. Infect Immun 1980; 29: 494-499.
13. Marquis G, Montplaisir S, Pelletier M, Mousseau S, Auger P. Genetic resistance to murine cryptococcosis: Increased susceptibility in the CBA/ N XID mutant strain of mice. Infect Immun 1985; 47: 282-287.
14. Huffnagle GB, Yates JL, Lipscomb MF. T cell-mediated immunity in the lung: A Cryptococcus neoformans pulmonary infection model using SCID and athymdc nude mice. Infect Immun 1991; 59: 1423-1433.
15. Lovchik JA, Wilder JA, Huffnagle GB, Riblet R, Lyons CR, Lipscomb MF. Ig heavy chain complex-linked genes influence the immune response in a murine cryptococcal infection. J Immunol 1999; 163: 3907-3913.
16. McClelland EE, Granger DL, Potts WK. Major histocompatibility complex-dependent susceptibility to Cryptococcus neoformans in mice. Infect Immun 2003; 71: 4815-4817.
17. Shao X, Mednick A, Alvarez M, van Rooijen N, Casadevall A, Goldman DL. An innate immune system cell is a major determinant of species-related susceptibility differences to fungal pneumonia. J Immunol 2005; 175: 3244-3251.
18. Huffnagle GB, Toews GB, Burdick MD, Boyd MB, McAllister KS, McDonald RA et al. Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. J Immunol 1996; 157: 4529-4536.
19. Huffnagle GB, Deepe GS. Innate and adaptive determinants of host susceptibility to medically important fungi. Curr Opin Microbiol 2003; 6: 344-350.
20. Herring AC, Lee J, McDonald RA, Toews GB, Huffnagle GB. Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection. Infect Immun 2002; 70: 2959-2964.
21. Kawakami K. Interleukin-18 and host defense against infectious pathogens. J Immunother (1997) 2002; 25: S12-S19.
22. Chen GH, Olszewski MA, McDonald RA, Wells JC, Paine III R, Huffnagle GB et al. Role of granulocyte macrophage colony-stimulating factor in host defense against pulmonary Cryptococcus neoformans infection during murine allergic bronchopulmonary mycosis. Am J Pathol 2007; 170: 1028-1040.
23. Huffnagle GB, Strieter RM, Standiford TJ, McDonald RA, Burdick MD, Kunkel SL et al. The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ T cells during a pulmonary Cryptococcus neoformans infection. J Immunol 1995; 155: 4790-4797.
24. Huffnagle GB, Strieter RM, McNeil LK, McDonald RA, Burdick MD, Kunkel SL et al. Macrophage inflammatory protein-1alpha (MIP-1alpha) is required for the efferent phase of pulmonary cell-mediated immunity to a Cryptococcus neoformans infection. J Immunol 1997; 159 318-327.
25. Mody CH, Lipscomb MF, Street NE, Toews GB. Depletion of CD4+ (L3T4+) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans. J Immunol 1990; 144: 1472-1477.
26. Lindell DM, Moore TA, McDonald RA, Toews GB, Huffnagle GB. Generation of antifungal effector CD8+ T cells in the absence of CD4+ T cells during Cryptococcus neoformans infection. J Immunol 2005; 174 7920-7928.
27. Goldman DL, Lee SC, Mednick AJ, Montella L, Casadevall A. Persistent Cryptococcus neoformans pulmonary infection in the rat is associated with intracellular parasitism, decreased inducible nitric oxide synthase expression, and altered antibody responsiveness to cryptococcal polysaccharide. Infect Immun 2000; 68: 832-838.
28. Huffnagle GB, Boyd MB, Street NE, Lipscomb MF. IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice (C57BL/6). J Immunol 1998; 160 2393-2400.
29. Hoag KA, Street NE, Huffnagle GB, Lipscomb MF. Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice. Am J Respir Cell Mol Biol 1995; 13: 487-495.
30. Feldmesser M, Kress Y, Casadevall A. Effect of antibody to capsular polysaccharide on eosinophilic pneumonia in murine infection with Cryptococcus neoformans. J Infect Dis 1998; 177: 1639-1646.
31. Van Wauwe J, Aerts F, Cools M, Deroose F, Freyne E, Goossens J et al Identification of R146225 as a novel, orally active inhibitor of interleukin-5 biosynthesis. J Pharmacol Exp Ther 2000; 295: 655-661.
32. Lovchik J, Lipscomb M, Lyons CR. Expression of lung inducible nitric oxide synthase protein does not correlate with nitric oxide production in vivo in a pulmonary immune response against Cryptococcus neoformans. J Immunol 1997; 158: 1772-1778.
33. Peters LL, Robledo RF, Bult CJ, Churchill GA, Paigen BJ, Svenson KL. The mouse as a model for human biology: A resource guide for complex trait analysis. Nat Rev 2007; 8: 58-69.
34. Hernandez Y, Arora S, Erb-Downward JR, McDonald RA, Toews GB, Huffnagle GB. Distinct roles for IL-4 and IL-10 in regulating T2 immunity during allergic bronchopulmonary mycosis. J Immunol 2005; 174: 1027-1036.
35. Herring AC, Falkowski NR, Chen GH, McDonald RA, Toews GB, Huffnagle GB. Transient neutralization of tumor necrosis factor alpha can produce a chronic fungal infection in an immunocompetent host: Potential role of immature dendritic cells. Infect Immun 2005; 73: 39-49.
36. Lander E, Kruglyak L. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results. Nat Genet 1995; 11: 241-247.
37. Dupuis J, Siegmund D. Statistical methods for mapping quantitative trait loci from a dense set of markers. Genetics 1999; 151: 373-386.
38. Phillips TJ, Belknap JK, Hitzemann RJ, Buck KJ, Cunningham CL, Crabbe JC. Harnessing the mouse to unravel the genetics of human disease. Genes Brain Behav 2002; 1: 14-26.
39. Mayfield JA, Rine J. The genetic basis of variation in susceptibility to infection with Histoplasma capsulatum in the mouse. Genes Immun 2007; 8: 468-474.
40. Fierer J, Walls L, Wright F, Kirkland TN. Genes influencing resistance to Coccidioides immitis and the interleukin-10 response map to chromosomes 4 and 6 in mice. Infect Immun 1999; 67: 2916-2919.
41. Tuite A, Elias M, Picard S, Mullick A, Gros P. Genetic control of susceptibility to Candida albicans in susceptible A/J and resistant C57BL/6J mice. Genes Immun 2005; 6: 672-682.
42. Lortholary O, Improvisi L, Fitting C, Cavaillon JM, Dromer F. Influence of gender and age on course of infection and cytokine responses in mice with disseminated Cryptococcus neoformans infection. Clin Microbiol Infect 2002; 8: 31-37.
43. Bruce AB. The Mendelian theory of heredity and the augmentation of vigor. Science 1910; 32: 627-628.
44. Strachan NJ, Watson RO, Novik V, Hofretter D, Ogden ID, Galan JE. Sexual dimorphism in campylobacteriosis. Epidemiol Infect 2007: 1-4.
45. Barna M, Komatsu T, Bi Z, Reiss CS. Sex differences in susceptibility to viral infection of the central nervous system. J Neuroimmunol 1996; 67: 31-39.
46. Satoskar A, Al-Quassi HH, Alexander J. Sex-determined resistance against Leishmania mexicana is associated with the preferential induction of a Th1-like response and IFN-gamma production by female but not male DBA/2 mice. Immunol Cell Biol 1998; 76: 159-166.
47. Guilbault C, Stotland P, Lachance C, Tam M, Keller A, Thompson-Snipes L et al. Influence of gender and interleukin-10 deficiency on the inflammatory response during lung infection with Pseudomonas aeruginosa in mice. Immunology 2002; 107: 297-305.
48. Yamamoto Y, Saito H, Setogawa T, Tomioka H. Sex differences in host resistance to Mycobacterium marinum infection in mice. Infect Immun 1991; 59: 4089-4096.
49. Styrt B, Sugarman B. Estrogens and infection. Rev Infect Dis 1991; 13: 1139-1150.
50. Mitsos LM, Cardon LR, Ryan L, LaCourse R, North RJ, Gros P. Susceptibility to tuberculosis: A locus on mouse chromosome 19 (Trl-4) regulates Mycobacterium tuberculosis replication in the lungs. Proc Natl Acad Sci USA 2003; 100: 6610-6615.
51. Fortin A, Cardon LR, Tam M, Skamene E, Stevenson MM, Gros P. Identification of a new malaria susceptibility locus (Char4) in recombinant congenic strains of mice. Proc Natl Acad Sci USA 2001; 98: 10793-10798.
52. Yang X, Schadt EE, Wang S, Wang H, Arnold AP, Ingram-Drake L et al Tissue-specific expression and regulation of sexually dimorphic genes in mice. Genome Res 2006; 16: 995-1004.
53. Kreutz R, Stock P, Struk B, Lindpaintner K. The Y chromosome. Epistatic and ecogenetic interactions in genetic hypertension. Hypertension 1996; 28: 895-897.
54. van Ooijen JW. Accuracy of mapping quantitative trait loci in autogamous species. Theor Appl Genet 1992; 84: 771-1022.
55. Broman KW. Review of statistical methods for QTL mapping in experimental crosses. Lab Anim 2001; 30: 44-52.
56. Soller M, Brody T, Genizi A. On the power of experimental designs for the detection of linkage between marker loci and quantitative loci in crosses between inbred lines. Theo Appl Genet 1976; 47: 35-39.
57. Allcock RJ, Martin AM, Price P. The mouse as a model for the effects of MHC genes on human disease. Immunol Today 2000; 21: 328-332.
58. Qiu H, Wang S, Yang J, Fan Y, Joyee AG, Han X et al. Resistance to chlamydial lung infection is dependent on major histocompatibility complex as well as non-major histocompatibility complex determinants. Immunology 2005; 116: 499-506.
59. Min-Oo G, Lindqvist L, Vaglenov A, Wang C, Fortin P, Li Y et al. Genetic control of susceptibility to pulmonary infection with Chlamydia pneumoniae in the mouse. Genes Immun 2008; 9: 383-388.
60. Lavebratt C, Apt AS, Nikonenko BV, Schalling M, Schurr E. Severity of tuberculosis in mice is linked to distal chromosome 3 and proximal chromosome 9. J Infect Dis 1999; 180: 150-155.
61. Sanchez F, Radaeva TV, Nikonenko BV, Persson AS, Sengul S, Schalling M et al. Multigenic control of disease severity after virulent Mycobacterium tuberculosis infection in mice. Infect Immun 2003; 71: 126-131.
62. Broman KW, Wu H, Sen S, Churchill GA. R/qtl: QTL mapping in experimental crosses. Bioinformatics (Oxford, England) 2003; 19: 889-890.